We are very happy to present Dustin McMinn for the next Chemical Biology lecture. As head of the Medicinal Chemistry department of Kezar Life Sciences, Dustin is leading the medicinal chemistry efforts toward the development of small-molecule modulators of protein secretion and supporting clinical development of a novel immunoproteasome inhibitor for treatment of autoimmune and inflammatory disorders.
Kezar Life Sciences, Inc. is a clinical-stage biotechnology company that engages in the discovery and development of small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. Its lead product candidate, KZR-616, a selective immunoproteasome inhibitor that is in Phase 1b/2 clinical trials in lupus and lupus nephritis. We look forward to getting a more industrial take on chemical biology in this presentation.
If you would like to meet with Dr McMinn, please contact Sander van Kasteren.